Long-term results of hip arthroplasty and determination of unfavorable risk factors for early development of osteonecrosis in patients with systemic lupus erythematosus

Aim of the study – to determine the risk factors for the early development of osteonecrosis and to analyze the results of surgical treatment of patients with systemic lupus erythematosus in the long term after total hip arthroplasty.

Materials and methods. The study group included 42 patients with systemic lupus erythematosus (SLE) complicated by osteonecrosis (ON) of the femoral head, who underwent 59 total hip arthroplasty (THA) operations. Before surgery and 6–21 years after THA, in order to assess the long-term results of surgical treatment of patients, the following was assessed: activity of the underlying disease – according to the SLEDAI-2K (Systemic Lupus Erythematosus Disease Activity Index 2000); the severity of irreversible changes in internal organs – according to the SLICC/ACR index of damage (Systemic Lupus International Collaborating Clinics/American College of Rheumatology); the clinical and functional state of the hip joint – according to the HHS (Harris Hip Score); the intensity of pain syndrome – according to the visual analogue scale (VAS); quality of life (QOL) – using the SF-36 questionnaire. The concentration of antibodies to cardiolipin (aCL) of IgM and IgG isotypes was determined by enzyme-linked immunosorbent assay (normal range – 0.0–10.0 GPL for IgM, 0–7 MPL for IgG).

Results. After 6–21 years of follow-up after THA, there was a statistically significant decrease in pain intensity according to VAS, improvement according to the HHS from 40.0±14.9 to 83.3±17.4 points, SLE activity according to the SLEDAI-2K from 0 to 20 points (median – 4 [4; 8] points) before surgery and from 0 to 41 points (median – 0 [0; 4] points) after a long period of observation. There was a pronounced statistically significant positive dynamics for all QOL indicators studied (p≤0.005 in all cases). The most significant changes were found on the scales RE (Role-Emotional), RP (Role-Physical Functioning) and BP (Bodily Pain). The early development of ON was associated with the degree of activity of the underlying disease, the cumulative dose of glucocorticoids, kidney damage and arthritis in the first year from the onset of SLE, as well as hematological disorders and the presence of aCL in the blood serum 3 years before the onset of ON. The total number of complications was 10.2%.

Conclusion. Total hip arthroplasty in patients with systemic lupus erythematosus can achieve a statistically significant reduction in pain intensity, increase functional activity and improve their quality of life.

1. Nasonov EL (ed.). Systemic lupus erythematosus. In: Rossiiskie klinicheskie rekomendatsii = Russian Clinical Recommendations. Moscow:GEOTAR-Media;2017:113-141 (In Russ.).

2. Kaul A. Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039. doi: 10.1038/nrdp.2016.39

3. Esdaile JM, Danoff D, Rosenthall L, Gutkowski A. Deforming arthritis in systemic lupus erythematosus. Ann Rheum Dis. 1981;40(2):124-126. doi: 10.1136/ard.40.2.124

4. Oinuma K, Harada Y, Nawata Y, Takabayashi K, Abe I, Kamikawa K, et al. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis. 2001;60(12):1145-1148. doi: 10.1136/ard.60.12.1145

5. Prasad R, Ibanez D, Gladman DD, Urowitz MB. The role of noncorticosteroid related factors in osteonecrosis (ON) in SLE: A nested case-control study of inception patients. Lupus. 2007;16:157-162. doi: 10.1177/0961203306075771

6. Nevskaya T, Gamble MP, Pope JE. A meta-analysis of avascular necrosis in systemic lupus erythematosus: Prevalence and risk factors. Clin Exp Rheumatol. 2017;35(4):700-710.

7. Gladman DD, Dhillon N, Su J, Urowitz MB. Osteonecrosis in SLE: Prevalence, patterns, outcomes and predictors. Lupus. 2018;27(1):76-81. doi: 10.1177/0961203317711012

8. Shakra M, Buskila D, Shoenfeld Y. Osteonecrosis in patients with SLE. Clin Rev Allergy Immunol. 2003;25(1):13-24. doi: 10.1385/CRIAI:25:1:13

9. Issa K, Naziri Q, Rasquinha VJ, Tatevossian T, Kapadia BH, Mont MA. Outcomes of primary total hip arthroplasty in systemic lupus erythematosus with a proximally-coated cementless stem. J Arthroplasty. 2013;28(9):1663-1666. doi: 10.1016/j.arth.2013.02.024

10. Kasturi S, Goodman S. Current perspectives on arthroplasty in systemic lupus erythematosus: Rates, outcomes, and adverse events. Curr Rheumatol Rep. 2016;18(9):59. doi: 10.1007/s11926-0160608-662

11. Kennedy JW, Khan W. Total hip arthroplasty in systemic lupus erythematosus: A systematic review. Int J Rheumatol. 2015;2015:475489. doi: 10.1155/2015/475489

12. Hochberg MC. Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. doi: 10.1002/art.1780400928

13. Aseeva EA, Solovyev SK, Nasonov EL. Current methods for evaluating the activity of systemic lupus erythematosus. Nauchcno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2013;51(2):186-200 (In Russ.). doi: 10.14412/1995-4484-2013-648

14. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51(4):737-755.

15. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):240-252. doi: 10.1002/acr.20543

16. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey. Manual and interpretation guide. Lincoln,RI:Quality Metric Incorporated;2000:150.

17. Amirdjanova VN, Goryachev DV, Korshunov NI, Rebrov AP, Sorotskaya VN. SF-36 questionnaire population quality of life indices. Nauchcno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2008;46(1):36-48 (In Russ.).

18. Thuboo J, Fong KY, Ng TP, Leong KH, Feng PH, Thio ST, et al. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Reumatol. 1999;26:97-102.

19. Schiffenbauer J, Simon LS. Randomized controlled trials in systemic lupus erythematosus: What has been done and what do we need to do? Lupus. 2004;13(5):398-405. doi: 10.1191/0961203303lu1033oa

20. Mukhanov VV, Rybnikov AV, Popkova TV, Makarov MA. Hip arthroplasty in patients with systemic lupus erythematosus. Nauchcno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(2):191-197 (In Russ.). doi: 10.14412/1995-4484-2020-191-197

21. Wang C, Mayo NE, Fortin PR. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol. 2001;28(3):525-532.

22. Thumboo J, Fong KY, Ng TP, Leong KH, Feng PH, Boey ML. Initial construct cross-cultural validation of the short form 36 for quality of life assessment of systemic lupus erythematosus patients in Singapore. Ann Acad Med Singap. 1997;26(3):282-284.

23. Friedman AW, Alarcón GS, McGwin GJr, Straaton KV, Roseman J, Goel N, et al. Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort study. LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture. Arthritis Care Res. 1999;12(4):256-266. doi: 10.1002/1529-0131(199908)12:4<256::aidart4>3.0.co;2-g

24. Boomsma MM, Bijl M, Stegeman CA, Kallenberg CG, Hoffman GS, Tervaert JW. Patients’ perceptions of the effects of systemic lupus erythematosus on health, function, income and interpersonal relationships: A comparison with Wegener’s granulomatosis. Arthritis Rheum. 2002;47(2):196-201. doi: 10.1002/art.10341

25. Mukhanov VV, Makarov SA, Makarov MA, Popkova TV. Early surgical outcomes after total hip replacement in systemic lupus erythematosus patients. Nauchcno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(4):451-455 (In Russ.). doi: 10.47360/1995-4484-2020-451-455